CLOUGH CAPITAL PARTNERS L P – Vertex Pharmaceuticals Incorporated Transaction History
CLOUGH CAPITAL PARTNERS L P portfolio value:
$4.25M
portfolio value
CLOUGH CAPITAL PARTNERS L P quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -9.66% | -1.57K shares | -328K | $289.54 | 14.68K |
| Q2 2022 | share | Decrease | -72.05% | -41.89K shares | -10.59M | $281.79 | 16.25K |
| Q1 2022 | share | Decrease | -45.71% | -48.96K shares | -8.34M | $260.97 | 58.15K |
| Q4 2021 | share | Increase | +19.53% | 17.5K shares | 7.26M | $222.45 | 107.11K |
| Q4 2021 | call | Decrease | -100.00% | -140K shares | -25.39M | $222.45 | 0 |
| Q3 2021 | call | Increase | +76.10% | 60.5K shares | 9.36M | $181.39 | 140K |
| Q3 2021 | share | 0.00% | 0 shares | -1.81M | $181.39 | 89.61K | |
| Q2 2021 | call | Decrease | -78.07% | -283K shares | -61.86M | $201.63 | 79.5K |
| Q2 2021 | share | Increase | +10.25% | 8.33K shares | 602K | $201.63 | 89.61K |
| Q1 2021 | call | Increase | +141.67% | 212.5K shares | 42.44M | $214.89 | 362.5K |
| Q1 2021 | share | Decrease | -6.14% | -5.32K shares | -3.00M | $214.89 | 81.28K |
| Q4 2020 | share | Increase | +14.99% | 11.29K shares | -26K | $236.34 | 86.6K |
| Q4 2020 | call | Increase | 0.00% | 150K shares | 35.45M | $236.34 | 150K |
| Q3 2020 | share | Increase | +146.11% | 44.71K shares | 11.61M | $272.12 | 75.31K |
| Q2 2020 | share | Decrease | -26.88% | -11.25K shares | -1.07M | $290.31 | 30.6K |
| Q1 2020 | share | Increase | +13.91% | 5.11K shares | 1.91M | $237.95 | 41.85K |
| Q4 2019 | share | Increase | +19.50% | 5.99K shares | 2.83M | $218.95 | 36.74K |
| Q3 2019 | share | Decrease | -0.97% | -300 shares | -484K | $169.42 | 30.74K |
| Q2 2019 | share | Decrease | -46.89% | -27.40K shares | -5.05M | $183.38 | 31.04K |
| Q1 2019 | share | Increase | +30.50% | 13.66K shares | 3.33M | $183.95 | 58.44K |
| Q4 2018 | share | Decrease | -2.02% | -923 shares | -1.38M | $165.71 | 44.78K |
| Q3 2018 | share | Decrease | -10.74% | -5.5K shares | 107K | $192.74 | 45.71K |
| Q2 2018 | share | Decrease | -13.26% | -7.83K shares | -919K | $169.96 | 51.21K |
| Q1 2018 | share | Decrease | -10.11% | -6.64K shares | -220K | $162.98 | 59.04K |
| Q4 2017 | share | Increase | +4.45% | 2.8K shares | 282K | $149.86 | 65.68K |
| Q3 2017 | share | Decrease | -2.33% | -1.5K shares | 1.26M | $152.04 | 62.88K |
| Q2 2017 | share | Decrease | -63.24% | -110.76K shares | -6.95M | $128.87 | 64.38K |
| Q1 2017 | share | Increase | +60.17% | 65.8K shares | 7.19M | $109.35 | 175.14K |
| Q4 2016 | share | Increase | +68.49% | 44.44K shares | 2.39M | $73.67 | 109.34K |
| Q3 2016 | share | Decrease | -22.55% | -18.9K shares | -1.54M | $87.21 | 64.9K |
| Q2 2016 | share | Decrease | -17.74% | -18.07K shares | -890K | $86.02 | 83.8K |
| Q1 2016 | share | Decrease | -39.98% | -67.85K shares | -13.25M | $79.49 | 101.87K |